Investment
Features
FeesSafety
Academy
More
Pluang+

Nuwellis expands Aquadex platform to support broader critical care therapies beyond ultrafiltration.

Market News
04 Aug 2026
GlobeNewsWire
View Source
Bullish
pluang ai news

Nuwellis announced plans to develop its Aquadex SmartFlow System into a versatile extracorporeal therapy platform, enhancing its capabilities to support higher blood flow rates and broader therapies like immunomodulation and blood purification. This expansion aims to address a wider range of critical care applications beyond fluid overload, potentially increasing the company's market reach. The initiative also positions Nuwellis for collaborations in advanced critical care treatments. These developments are in the research stage and not yet FDA approved.

More News (NUWE)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App